FDA Inspection 903954 — Sher Fertility Solutions New York

Sher Fertility Solutions New York — FEI 3005202232

The FDA completed an inspection of Sher Fertility Solutions New York on December 5, 2014 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 5, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1222221 CFR 1271.47(a)Design of procedures to ensure compliance
1222921 CFR 1271.50(a)Determination based on screening and testing
1224221 CFR 1271.55(c)Name and personal info on accompanying records
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results